|本期目录/Table of Contents|

[1]中华医学会感染病学分会,中华医学会热带病与寄生虫学分会,中华中医药学会急诊分会.中国登革热临床诊断和治疗指南[J].传染病信息,2018,05:385-392.
 Infectious Diseases,Society of Tropical Medicine and Parasitology,Chinese Medical Association Society of Emergency Medicine,et al.Guidelines for diagnosis and treatment of dengue in China[J].Infectious Disease Information,2018,05:385-392.
点击复制

中国登革热临床诊断和治疗指南(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2018年05期
页码:
385-392
栏目:
特别报道
出版日期:
2018-10-30

文章信息/Info

Title:
Guidelines for diagnosis and treatment of dengue in China
作者:
中华医学会感染病学分会中华医学会热带病与寄生虫学分会中华中医药学会急诊分会 
Author(s):
Infectious Diseases Society of Tropical Medicine and Parasitology Chinese Medical Association Society of Emergency Medicine China Association of Chinese Medicine
关键词:
登革热诊断治疗指南中国
Keywords:
dengue diagnosis treatment guidelines China
分类号:
R512.8
DOI:
10.3969/j.issn.1007-8134.2018.05.001
文献标识码:
A
摘要:
-
Abstract:
-

参考文献/References


[1] World Health Organization. Dengue: guidelines for diagnosis,reatment, evention and control[EB /OL].(2009-10-01)[2018-01-01]. http://www. who. int/tdr /publications/documents /dengue-diagnosis. pdf.
[2] 国家卫生计生委. 登革热诊疗指南(第 2 版)[EB /OL].http: //www. nhfpc. gov.cn /yzygj /s3593g /201410 /d417aa2e783949e48f8a7366d7fdfacc. shtml.
[3] 中华人民共和国卫生部. 登革热诊断标准[S]. 北京:人民卫生出版社,2008.
[4] 中国疾病预防控制中心. 中国疾病预防控制中心关于印发登革热防治技术指南的通知[Z]. 中疾控传防发〔2014〕360 号.
[5] Kularatne SA. Dengue fever[J]. BMJ, 2015, 351: h4661.
[6] 张复春,杨智聪. 登革热[M]. 科学出版社, 2008.
[7] Murphy BR, Whitehead SS. Immune response to dengue virus andprospects for a vaccine[J]. Annu Rev Immunol, 2011, 29:587-619.
[8] Bhatt S, Gething PW, Brady OJ, et al. The global distribution andburden of dengue[J]. Nature, 2013, 496(7446):504-507.
[9] Shepard DS, Undurraga EA, Halasa YA, et al. The global economicburden of dengue: a systematic analysis[J]. Lancet Infect Dis,2016, 16(8):935-941.
[10] Castro MC, Wilson ME, Bloom DE. Disease and economic burdensof dengue[J]. Lancet Infect Dis, 2017, 17(3):e70-e78.
[11] 张复春. 中国登革热现状[J]. 新发传染病电子杂志,2018,3(2):65-66.
[12] 张萌,何剑锋. 登革热流行趋势研究进展[J]. 新发传染病电子杂志,2018,3(2):72-74.
[13] Zhang FC, Zhao H, Li LH, et al. Severe dengue outbreak inYunnan, China, 2013[J]. Int J Infect Dis, 2014, 27:4-6.
[14] Lai S, Huang Z, Zhou H, et al. The changing epidemiology ofdengue in China, 1990-2014: a descriptive analysis of 25 years ofnationwide surveillance data[J]. BMC Med, 2015, 13:100.
[15] Shen SQ, Wei HX, Fu YH, et al. Multiple Sources of Infection andPotential Endemic Characteristics of the Large Outbreak of Denguein Guangdong in 2014[J]. Sci Rep, 2015, 5:16913.
[16] Huang XY, Ma HX, Wang HF, et al. Outbreak of dengue Fever incentral China, 2013[J]. Biomed Environ Sci, 2014, 27(11):894-897.
[17] Sharp TM, Tomashek KM, Read JS, et al. A New Look at an OldDisease: Recent Insights into the Global Epidemiology of Dengue [J]. Curr Epidemiol Rep, 2017, 4(1):11-21.
[18] Zhang F, Tang X, Hu X, et al. A clinical, epidemiology andvirological study of a dengue fever outbreak in Guangzhou,China-2002-2006[J]. Dengue Bulletin, 2007, 31:10-18.
[19] Global strategy for dengue prevention and control, 2012–2020.WHO, 2012.
[20] 秦鄂德,秦成峰,姜涛. 登革病毒与登革病毒病[M]. 科学出版社,2008.
[21] Muller DA, Young PR. The flavivirus NS1 protein: molecularand structural biology, immunology, role in pathogenesis andapplication as a diagnostic biomarker[J]. Antiviral Res, 2013,98(2):192-208.
[22] Rothman AL. Immunity to dengue virus: a tale of original antigenicsin and tropical cytokine storms[J]. Nat Rev Immunol, 2011,11(8):532-543.
[23] Halstead SB. Dengue[J]. Lancet, 2007, 370(9599):1644-1652.
[24] Guzman MG, Harris E. Dengue[J]. Lancet, 2015, 385(9966):453-465.
[25] St JA, Abraham SN, Gubler DJ. Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis [J]. Nat Rev Microbiol, 2013, 11(6):420-426.
[26] Screaton G, Mongkolsapaya J, Yacoub S, et al. New insights intothe immunopathology and control of dengue virus infection[J].Nat Rev Immunol, 2015, 15(12):745-759.
[27] 张复春. 登革热的诊断与治疗[M]. 人民卫生出版社,2014.
[28] Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinicaland laboratory indicators of acute dengue illness[J]. J Infect Dis,1997, 176(2):313-321.
[29] Simmons CP, Farrar JJ, Nguyen V, et al. Dengue[J]. N Engl JMed, 2012, 366(15):1423-1432.
[30] Hunsperger EA, Yoksan S, Buchy P, et al. Evaluation ofcommercially available diagnostic tests for the detection of denguevirus NS1 antigen and anti-dengue virus IgM antibody[J]. PLoSNegl Trop Dis, 2014, 8(10):e3171.
[31] Muller DA, Depelsenaire AC, Young PR. Clinical and LaboratoryDiagnosis of Dengue Virus Infection[J]. J Infect Dis,2017,215(suppl_2):S89-S95.
[32] Handbook for clinical management of dengue. WHO, 2012.
[33] Lye DC, Archuleta S, Syed-Omar SF, et al. Prophylactic platelettransfusion plus supportive care versus supportive care alonein adults with dengue and thrombocytopenia: a multicentre,open-label, randomised, superiority trial[J]. Lancet, 2017,389(10079):1611-1618.
[34] 洪文昕,王建,邱爽,等. 121 例成人重症登革热的临床特征及救治体会[J]. 中山大学学报(医学科学版),2016,(3):333-336.
[35] 广东省重症登革热诊疗指引(2014 年第2 版). 广东省卫生和计生委员会,2014.
[36] 应若素,王建,洪文昕,等. 广东省2014 年登革热暴发流行的临床和实验室特点[J]. 中华传染病杂志,2014,(12):719-723.
[37] 马家驹,王玉光,谭行华,等. 探析2014 年登革热之中医证治[J]. 环球中医药,2014(12):934-936.
[38] 韩凡,莫锦,覃小兰,等. 从257 例病例中探讨登革热的中医临床辨治[J]. 广州中医药大学学报,2014(6):855-859.
[39] 叶志中,刘南,余锋,等. 210例登革热患者中医证候分析[J].广州中医药大学学报,2015(1):15-18.
[40] 张沛,谭行华,张复春,等. 377 例登革热中医症候特点分析[J]. 中华中医药杂志,2015(7):2532-2534.
[41] 刘领弟,刘娇,林路平,等. 345 例登革热中医证候学特征及病因病机分析[J]. 中国中医急症,2016(7):1316-1318.
[42] 郭世俊,蔡海荣,黄永莲,等. 2014 年广州大学城登革热的临床特征分析[J]. 广州中医药大学学报,2015(5):796-798.
[43] Katzelnick LC, Coloma J, Harris E. Dengue: knowledge gaps,unmet needs, and research priorities[J]. Lancet Infect Dis,2017, 17(3):e88-e100.
[44] Low JG, Ooi EE, Vasudevan SG. Current Status of DengueTherapeutics Research and Development[J]. J Infect Dis, 2017,215(suppl_2):S96-S102.
[45] Halstead SB. Critique of World Health OrganizationRecommendation of a Dengue Vaccine[J]. J Infect Dis, 2016,214(12):1793-1795.

备注/Memo

备注/Memo:
[ 基金项目] 国家科技重大专项课题(2017ZX103055001- 003); 广东省科技专项资金项目 (2013A020229001, 2013A020229002);广州市健康医疗协同创新重大计划项目(201508020263,201803040006);广州市临床医学研究与转化中心试点建设项目(2014Y2-00550)
[ 通信作者] 王贵强,E-mail: john131212@sina.com
更新日期/Last Update: 2018-10-30